Product Code: 1964
Interventional Cardiology & Peripheral Vascular Devices Market is expected to depict strong growth through 2032, owing to the increasing technological innovations in peripheral vascular devices. Technological advances such as drug-eluting stents, nanotechnology, drug-coated balloons, and several other breakthroughs are anticipated to increase the procedure outcome and success rate.
Strategic M&A and innovative product launches are key efforts undertaken by conglomerates to expand their presence and business operations across the global market. For instance, in February 2023, Abbott acquired the medical device company Cardiovascular Systems (CSI) in a deal worth around USD 890 million. With this acquisition, CSI will add complementary technologies to Abbott's primary vascular device offerings.
Overall, the interventional cardiology and peripheral vascular devices industry is segmented in terms of product, application, end-use and region.
Based on the product, the interventional catheters product segment will witness significant growth through 2032. The increasing demand for minimally invasive procedures for cardiac disorders would contribute to the segmental growth. Moreover, advantages such as reduced hemostasis and vascular complications will further favor the segmental expansion in the coming years.
By application, the coronary thrombectomy segment will depict strong growth through 2032. Coronary thrombectomy is a catheter-based, minimally invasive procedure to remove blood clots.
IC & PVC devices are crucial in this application for lowering the risk of excessive bleeding and improving patient survival rates.
Considering the end-use, the hospitals segment is estimated to reach over USD 19 billion between 2023-2032. Increasing adoption of cardiac procedures in hospitals due to their significant performance in hospital settings will stimulate the demand for IC and PVD devices. In addition, new product launches in the cardiac ablation industry will also spur the product adoption in hospitals, thereby boosting the product demand.
From a regional perspective, the Asia Pacific interventional cardiology and peripheral vascular devices market is expected to depict over 8% CAGR through 2032. The increasing prevalence of cardiovascular diseases will positively favor the regional market outlook. Furthermore, the presence of leading players as well as local manufacturers who are constantly investing heavily in the healthcare segment to improve healthcare facilities will foster the market growth in the region.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Industry coverage
- 1.2 Market scope & definitions
- 1.3 Base estimates & working
- 1.3.1 North America
- 1.3.2 Europe
- 1.3.3 Asia Pacific
- 1.3.4 Latin America
- 1.3.5 MEA
- 1.4 Forecast parameters
- 1.5 COVID-19 impact analysis at global level
- 1.6 Data validation
- 1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
- 1.7.2.1 Paid sources
- 1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Interventional cardiology & peripheral vascular devices industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Interventional Cardiology & Peripheral Vascular Devices Industry Insights
- 3.1 Industry landscape, 2018 - 2032
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing prevalence of vascular diseases worldwide
- 3.2.1.2 Technological advancements in peripheral vascular devices
- 3.2.1.3 Rising adoption of minimally invasive procedures
- 3.2.1.4 Increasing government spending pertaining to cardiovascular diseases burden
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Stringent regulatory framework
- 3.2.2.2 Post-procedural complications associated with devices
- 3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.3.3 By end-use
- 3.4 COVID-19 impact analysis
- 3.5 Regulatory landscape
- 3.6 Patent analysis
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
- 4.1 Introduction
- 4.2 Competitive dashboard, 2021
- 4.3 Company matrix analysis, 2021
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategic outlook matrix
Chapter 5 Interventional Cardiology & Peripheral Vascular Devices Market, By Product
- 5.1 Key product trends
- 5.2 Interventional catheters
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3 Guidewires
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4 Stents
- 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.2 Bioabsorbable stents
- 5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.3 Drug eluting stents
- 5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.4 Bare metal stents
- 5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.5 Others
- 5.4.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.5 PTCA balloons
- 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.6 Atherectomy devices
- 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.7 Chronic total occlusion devices
- 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.8 Synthetic surgical grafts
- 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.9 Embolic protection devices
- 5.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.10 Inferior vena cava filters
- 5.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.11 Others
- 5.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Interventional Cardiology & Peripheral Vascular Devices Market, By Application
- 6.1 Key application trends
- 6.2 Congenital heart defect correction
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3 Coronary thrombectomy
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.4 Angioplasty
- 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.5 Valvuloplasty
- 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.6 Percutaneous valve repair
- 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.7 Others
- 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Interventional Cardiology & Peripheral Vascular Devices Market, By End-use
- 7.1 Key end-use trends
- 7.2 Hospital
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.3 Ambulatory surgical centers
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 7.4 Others
- 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Interventional Cardiology & Peripheral Vascular Devices Market Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Poland
- 8.3.7 The Netherlands
- 8.3.8 Sweden
- 8.3.9 Austria
- 8.3.10 Denmark
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Thailand
- 8.4.7 Singapore
- 8.4.8 Indonesia
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Chile
- 8.5.5 Colombia
- 8.5.6 Peru
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Israel
- 8.6.5 Egypt
Chapter 9 Company Profiles
- 9.1 Abbott Laboratories
- 9.2 Medtronic Plc
- 9.3 B. Braun Melsungen AG
- 9.4 Boston Scientific Corporation
- 9.5 AngioDynamics
- 9.6 Biotronik SE & Co. KG
- 9.7 Cook Medical
- 9.8 W.L. Gore & Associates, Inc.
- 9.9 Teleflex Inc.
- 9.10 Cardinal Health
- 9.11 C. R. Bard (Becton Dickinson and Company)